Cargando…
A simple mechanistic terminology of psychoactive drugs: a proposal
Antidepressants, antiepileptics, mood stabilizers, and antipsychotics are extremely broadly used psychoactive drugs. These drug terms are universally used in the literature. However, the indications of these drugs have broadened substantially and overlap. The mismatch between drug classification and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351828/ https://www.ncbi.nlm.nih.gov/pubmed/32535698 http://dx.doi.org/10.1007/s00210-020-01918-x |
_version_ | 1783557523607912448 |
---|---|
author | Seifert, Roland Schirmer, Bastian |
author_facet | Seifert, Roland Schirmer, Bastian |
author_sort | Seifert, Roland |
collection | PubMed |
description | Antidepressants, antiepileptics, mood stabilizers, and antipsychotics are extremely broadly used psychoactive drugs. These drug terms are universally used in the literature. However, the indications of these drugs have broadened substantially and overlap. The mismatch between drug classification and clinical uses causes a lot of confusion in communication and renders literature searches increasingly difficult. Therefore, we propose to drop the above terms altogether and replace them by simple mechanistic terms. Antidepressants are re-named as norepinephrine/serotonin (NE/5-HT) enhancers, antiepileptics comprising drugs with different mechanisms become neuronal inhibitors with pleiotropic effects (NIPEs), and antipsychotics become antagonists at multiple G protein–coupled receptors (mGPCR antagonists). Alkali metal ions, comprising lithium, are integrated into NIPEs. The terms “typical/first-generation/conventional” and “atypical/second-generation/non-conventional” antipsychotics should be dropped, because the original criterion for distinction, i.e., the presence and absence of extrapyramidal motor effects, respectively, is not valid anymore. The suggested changes in drug nomenclature have already been implemented into a recent textbook (Seifert R, Basic Knowledge of Pharmacology). The revised nomenclature ensures consistency with other fields of pharmacology and assignment of drug classes to indications without causing confusion. The authors acknowledge that the change in drug nomenclature is a cultural process that will take time and openly discuss the problems associated with the proposal. Ultimately, international learned societies will have to agree on a new nomenclature. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00210-020-01918-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7351828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-73518282020-07-14 A simple mechanistic terminology of psychoactive drugs: a proposal Seifert, Roland Schirmer, Bastian Naunyn Schmiedebergs Arch Pharmacol Review Article Antidepressants, antiepileptics, mood stabilizers, and antipsychotics are extremely broadly used psychoactive drugs. These drug terms are universally used in the literature. However, the indications of these drugs have broadened substantially and overlap. The mismatch between drug classification and clinical uses causes a lot of confusion in communication and renders literature searches increasingly difficult. Therefore, we propose to drop the above terms altogether and replace them by simple mechanistic terms. Antidepressants are re-named as norepinephrine/serotonin (NE/5-HT) enhancers, antiepileptics comprising drugs with different mechanisms become neuronal inhibitors with pleiotropic effects (NIPEs), and antipsychotics become antagonists at multiple G protein–coupled receptors (mGPCR antagonists). Alkali metal ions, comprising lithium, are integrated into NIPEs. The terms “typical/first-generation/conventional” and “atypical/second-generation/non-conventional” antipsychotics should be dropped, because the original criterion for distinction, i.e., the presence and absence of extrapyramidal motor effects, respectively, is not valid anymore. The suggested changes in drug nomenclature have already been implemented into a recent textbook (Seifert R, Basic Knowledge of Pharmacology). The revised nomenclature ensures consistency with other fields of pharmacology and assignment of drug classes to indications without causing confusion. The authors acknowledge that the change in drug nomenclature is a cultural process that will take time and openly discuss the problems associated with the proposal. Ultimately, international learned societies will have to agree on a new nomenclature. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00210-020-01918-x) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-06-13 2020 /pmc/articles/PMC7351828/ /pubmed/32535698 http://dx.doi.org/10.1007/s00210-020-01918-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Review Article Seifert, Roland Schirmer, Bastian A simple mechanistic terminology of psychoactive drugs: a proposal |
title | A simple mechanistic terminology of psychoactive drugs: a proposal |
title_full | A simple mechanistic terminology of psychoactive drugs: a proposal |
title_fullStr | A simple mechanistic terminology of psychoactive drugs: a proposal |
title_full_unstemmed | A simple mechanistic terminology of psychoactive drugs: a proposal |
title_short | A simple mechanistic terminology of psychoactive drugs: a proposal |
title_sort | simple mechanistic terminology of psychoactive drugs: a proposal |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351828/ https://www.ncbi.nlm.nih.gov/pubmed/32535698 http://dx.doi.org/10.1007/s00210-020-01918-x |
work_keys_str_mv | AT seifertroland asimplemechanisticterminologyofpsychoactivedrugsaproposal AT schirmerbastian asimplemechanisticterminologyofpsychoactivedrugsaproposal AT seifertroland simplemechanisticterminologyofpsychoactivedrugsaproposal AT schirmerbastian simplemechanisticterminologyofpsychoactivedrugsaproposal |